You've never seen anything like it · Doors open inStarts at 7:00 PM ET
Skip to content

Research compound · Melanocortin research

Chorionic gonadotropin (hCG)

Also known as human chorionic gonadotropin · CG

A heterodimeric glycoprotein hormone rather than a peptide: an alpha subunit and a beta subunit, together about 237 amino acids, carrying extensive N-linked and O-linked glycosylation.

Compound type
Research compound
Research area
Melanocortin
Length
237 residues

What it is

Chorionic gonadotropin is a glycoprotein hormone, not a peptide. It is a non-covalent heterodimer of two different subunits totaling about 237 amino acid residues, and roughly a third of its mass is carbohydrate. Because the oligosaccharide chains vary between preparations and between glycoforms, there is no single reference molecular mass for the molecule, which is why the identity block for this entry gives an approximate basis rather than a formula.

It belongs to the glycoprotein hormone family together with lutropin, follitropin and thyrotropin. All four share a common alpha subunit, and the beta subunit is what distinguishes one hormone from another and determines which receptor it engages 2. Chorionic gonadotropin and lutropin share a receptor, the luteinizing hormone and chorionic gonadotropin receptor.

Structure and chemistry

The crystal structure published in 1994 showed that each subunit adopts the same topology, with three disulfide bonds forming a cystine knot, a folding motif also found in some protein growth factors. The heterodimer is stabilized by a segment of the beta subunit that wraps around the alpha subunit and is fastened like a seat belt by the disulfide between Cys26 and Cys110, a feature the authors described as essential both for heterodimer association and for receptor binding by the glycoprotein hormones 1.

The carbohydrate is not decoration. Both subunits carry N-linked glycans, and the beta subunit of this hormone has an additional C-terminal extension bearing O-linked chains that the other family members lack. Enzymatic deglycosylation experiments on the separated subunits examined how the sugar chains contribute to formation of tertiary structure and to activity in assay systems 3.

How it is studied in the laboratory

Work on the molecule itself is structural and biochemical: X-ray crystallography of the heterodimer 1, chemical and enzymatic dissection of the subunits and their glycans 3, and comparative studies across the glycoprotein hormone family 2. Receptor pharmacology is studied in cell systems expressing the lutropin and chorionic gonadotropin receptor, a class A G protein-coupled receptor, with second-messenger readouts.

Because the molecule is a glycoprotein of variable composition, activity is compared between preparations by bioassay against a reference material rather than by mass alone.

Analytical notes

A single mass measurement does not establish identity for a glycoprotein of this size. Confirmation uses intact-mass measurement on a high-resolution instrument, which resolves a distribution of glycoforms rather than one peak, together with peptide mapping, in which the protein is digested and the fragments matched against the expected sequence. Released-glycan profiling characterizes the carbohydrate separately.

Subunit dissociation is a practical concern, since the heterodimer is held together non-covalently. Denaturing conditions separate the subunits, so native or gentle methods are needed when the intact dimer is the analyte. Size-exclusion chromatography is used to check for aggregates and for free subunits.

Storage and handling in the laboratory

As supplied, the material is a lyophilized powder, stored sealed and protected from light, typically at -20 degrees Celsius or below. Glycoproteins are more sensitive than small peptides to surface adsorption and to repeated freezing and thawing of solutions, so aliquoting at first use is standard practice. Carrier protein is sometimes added to dilute solutions for the same reason.

Open questions in the literature

Glycoform heterogeneity is the central analytical problem: preparations from different sources differ in their glycan distribution, and that difference is not captured by sequence or by intact mass alone, which complicates comparison of results between laboratories. Structural work also leaves the conformational changes on receptor engagement incompletely described.

References

  1. Lapthorn AJ, Harris DC, Littlejohn A, Lustbader JW, Canfield RE, Machin KJ, Morgan FJ, Isaacs NW. Crystal structure of human chorionic gonadotropin. Nature. 1994;369(6480):455-461. doi:10.1038/369455a0. Source
  2. Pierce JG, Parsons TF. Glycoprotein hormones: structure and function. Annual Review of Biochemistry. 1981;50:465-495. doi:10.1146/annurev.bi.50.070181.002341. Source
  3. Goverman JM, Parsons TF, Pierce JG. Enzymatic deglycosylation of the subunits of chorionic gonadotropin. Effects on formation of tertiary structure and biological activity. Journal of Biological Chemistry. 1982;257(24):15059-15064. Source

For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any disease.